WO2013131637A1 - Dispositif photo-acoustique - Google Patents

Dispositif photo-acoustique Download PDF

Info

Publication number
WO2013131637A1
WO2013131637A1 PCT/EP2013/000635 EP2013000635W WO2013131637A1 WO 2013131637 A1 WO2013131637 A1 WO 2013131637A1 EP 2013000635 W EP2013000635 W EP 2013000635W WO 2013131637 A1 WO2013131637 A1 WO 2013131637A1
Authority
WO
WIPO (PCT)
Prior art keywords
optical
optical radiation
acoustic
cavity
cell
Prior art date
Application number
PCT/EP2013/000635
Other languages
German (de)
English (en)
Inventor
Hermann VON LILIENFELFD-TOAL
Original Assignee
Elte Sensoric Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elte Sensoric Gmbh filed Critical Elte Sensoric Gmbh
Publication of WO2013131637A1 publication Critical patent/WO2013131637A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
    • A61B5/0095—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1702—Systems in which incident light is modified in accordance with the properties of the material investigated with opto-acoustic detection, e.g. for gases or analysing solids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Definitions

  • the invention relates to a photoacoustic device for measuring a chemical substance in a medium, in particular for measuring the concentration of glucose in the body of a patient.
  • Diabetes patients need to monitor their blood glucose levels regularly. Usually, a blood sample is taken and examined outside the patient's body. Patients themselves monitoring their blood sugar levels use a small finger lance to extract a drop of blood, which they dab on a reagent strip for analysis. This process is uncomfortable and painful. Therefore, alternatives are sought to avoid blood sampling and to monitor blood glucose levels noninvasively in vivo.
  • One such alternative is the measurement of glucose by infrared spectroscopy using a laser beam that enters the patient's body through the skin.
  • the glucose-specific absorption of the laser beam at certain optical wavelengths is measured.
  • EP 1 048 265 A1 discloses an apparatus for infrared spectroscopic measurement of glucose using laser light in the mid-infrared range, that is to say at wavelengths in the range from 2.5 ⁇ m to 25 ⁇ m.
  • Substances like glucose consist of molecules with covalent bonds whose fundamental vibrations have resonance frequencies in the mid-infrared range of the light spectrum.
  • the absorption spectrum of these substances therefore contains particularly narrow-band absorption lines characteristic of the particular substance in the mid-infrared range.
  • the absorption lines are mostly due to harmonics of the vibrating molecular bonds and are wider and overlap more so that they are less likely to be associated with the substance of interest.
  • the transmitted radiation intensity is very small and hardly accessible to an optical measurement for recording an absorption spectrum.
  • the optical absorption coefficient is therefore measured via the photoacoustic effect.
  • the optical absorption of the infrared light leads to the excitation of molecular vibrations. such as vibrational modes of C-0 bonds in glucose.
  • the energy thus absorbed is released via non-radiative transitions as heating to the surrounding medium.
  • the material stress and thermal expansion of the matter detected by the heating results in an acoustic wave which is detected by an acoustic sensor.
  • the sensor is a photoacoustic cell with a gas filled cavity and a microphone for detecting sound waves in the cavity.
  • the photoacoustic cell is placed on the skin surface of the patient, which is then pulsed optically irradiated.
  • the irradiation leads to pulse-like heating according to the optical absorption.
  • the heats trigger acoustic pressure waves in the cavity, which are detected with the microphone.
  • Amplification of the acoustic waves can be achieved by tuning the frequency at which the optical pulses follow one another to the acoustic resonance frequency of the gas-filled cavity.
  • the amplitude of the acoustic signal received by the microphone corresponds to the optical absorption coefficient of the light-irradiated tissue of the patient at the selected optical wavelength.
  • the repetition of the measurement at different optical wavelengths allows the recording of different regions of an absorption spectrum, from which the concentration of the substance of interest, for example glucose can be tapped.
  • the described prior art allows a quantitative measurement of the glucose concentration, the sensitivity and accuracy of which, however, does not yet reach that of a measurement with the above-mentioned reagent strips.
  • the invention is therefore based on the object to provide a device with improved sensitivity for measuring a substance in a medium.
  • the pulse frequency in the invention is in the ultrasonic frequency range, that is more than 16 kHz. It is preferably more than 30 or 40 or 50 kHz.
  • the pulse frequency for each of the lower limits should be less than 200 kHz, preferably less than 120 kHz or 90 or 70 kHz.
  • the pulse frequency is also a resonant frequency of the cavity of the photoacoustic cell. As a result, the following effect is achieved. With increasing frequency in the ultrasonic range, the photoacoustic cell is less susceptible to noise.
  • the photoacoustic cell can be built smaller with increasing pulse frequency.
  • a smaller cavity also causes a higher sound pressure of the acoustic wave formed in it, whereby the sensitivity of the device is increased.
  • Exceeding the upper limits of the pulse frequency however, the sensitivity of the available acoustic transducer for detecting the acoustic wave and output of an electrical measurement signal decreases, since the inertia of the moving parts of the transducer attenuates higher-frequency vibrations.
  • the stratum spinosum contains a glucose concentration which, with only a slight delay, follows the blood glucose concentration of interest to diabetics.
  • the stratum corneum called outer skin layer is only a few microns thick.
  • the information on the thickness of the stratum corneum previously published in the scientific community was always too large due to swelling of the stratum corneum during sample preparation.
  • the clinically relevant glucose concentration can be achieved even with light of relatively low penetration depth in the middle infrared range at the absorption lines of glucose.
  • the location of the optical absorption is very close to the photoacoustic cell.
  • the thermal wave resulting from the optical absorption in the interstitial fluid which is converted into an acoustic wave in the photoacoustic cell, as well as the resulting when the heat wave in the interstitial fluid with the resulting acoustic wave of the photoacoustic see cell be detected.
  • the thermal or acoustic wave triggered by an optical pulse reaches the transducer very quickly and the next optical pulse can follow already after a short time. At high pulse frequency results in a short time a significant signal.
  • Claims 2 to 7 relate to expedient embodiments of the device according to the invention, in particular for the non-invasive measurement of glucose in the body of a patient.
  • the features of claim 8 allow the detection of the optical absorption at several absorption lines and at least one reference wavelength away from the absorption lines of glucose simultaneously. Therefore, in a short measuring time, a sufficient amount of data can be obtained for a precise measurement.
  • claims 9 to 11 have the advantage that the amplitude of the measurement signal detected by the photoacoustic cell is relatively independent of fluctuations in the pressure, the temperature and the moisture content of the gas in the cavity of the cell.
  • the optical radiation is incident through a first opening in the cavity of the photoacoustic cell and exits through an opposite second opening again.
  • the patient places a finger or his hand with the skin surface on the second opening. If there is no window to define the cavity, the optical radiation can occur undamped on the skin surface, and the acoustic and thermal wave resulting from absorption by glucose can directly reach the gas in the cavity and cause the acoustic wave there directly and by thermal expansion of the gas.
  • a zinc selenide window for transmitting the mid-infrared optical radiation is provided on the first opening.
  • the omission of such a window slightly widens the acoustic resonance line of the cavity so that the amplitude of the acoustic wave is less affected by slight shifts in the acoustic resonance frequency as may occur with variations in temperature, humidity or pressure of the gas in the cavity of the cell .
  • the omission of the window on the first opening provides for good ventilation of the cavity and avoids a resonance behavior changing moisture precipitate in the cavity when the patient's skin on the second opening is moist.
  • FIG. 1 shows the schematic representation of a photoacoustic device according to an embodiment of the invention
  • FIG. 2 shows a cross section in the vertical plane through a photoacoustic cell in the exemplary embodiment according to FIG. 1,
  • FIG. 3 shows a cross section in the horizontal plane through the photoacoustic cell of the device according to FIG. 1,
  • Figure 4 shows the acoustic resonance spectrum of the photoacoustic cell of the embodiment of Figures 1 to 3, and
  • Figure 5 is a vertical cross-section through a photoacoustic cell, which is a concrete embodiment of the cell shown in Figure 2.
  • Figure 1 shows an embodiment of a photoacoustic device for measuring a chemical substance in a medium which is particularly suitable for non-invasive measurement of the concentration of glucose in the body of a patient.
  • the device comprises an optical source 1, a concave mirror 4, a photoacoustic cell 2 and a control circuit 3.
  • the optical source 1 includes (not shown) six quantum cascade lasers for emitting optical radiation 5 focused from the mirror 4 into the photoacoustic cell 2 from below and incident on the skin surface of a finger (not shown) on top of the photoacoustic cell 2 impinging on a patient's hand.
  • the optical radiation 5 contains six components, one of each of which is emitted by one of the quantum cascade lasers.
  • the components of five of the quantum cascade lasers are mid-infrared radiation at wavelengths at which absorption maxima in the absorption spectrum of glucose in the body of a patient occur, for example at wavenumbers of 1151, 1105, 1080, 1036 and 992 cm-.
  • the component of the sixth quantum cascade laser is infrared radiation of a wavelength at an absorption minimum of glucose in the body of the patient, for example at a wavenumber of 1170, 1140, 1094, 1066, 1014 or 960 cm- 1 .
  • the quantum cascade lasers are driven by the control circuit 3 for the simultaneous delivery of these radiation components in pulses according to the following scheme:
  • Two quantum cascade lasers are driven to emit their two radiation components in pulses of a repetition frequency of 56 kHz and with a phase difference of 90 ° between the components.
  • Two more The quantum cascade lasers are driven to emit their two radiation components in pulses of a repetition frequency of 60 kHz and with a phase difference of 90 °.
  • the two other quantum cascade lasers are driven to deliver their two radiation components in pulses of a repetition frequency of 64 kHz and a mutual phase difference of also 90 °.
  • the control takes place via control signals 6 from the control circuit 3 to the optical source.
  • the photoacoustic cell 2 outputs an electrical measurement signal 7 to the control circuit 3, which contains six Meßsignalkomponenten corresponding to the number of optical radiation components.
  • the frequency and phase of a respective measurement signal component correspond to the pulse frequency and phase of the optical radiation component, the absorption of which in the skin of the patient causes the measurement signal component.
  • the amplitude of the measurement signal component corresponds to the absorption coefficient of the irradiated tissue of the patient at the wavelength of the optical radiation component.
  • the six measuring signal components for example, by means of six lock-in amplifiers or a correspondingly programmed signal processor (not shown) using the control signals 6 as a reference from each other and separated from any noise and the six amplitudes of the Meßsignalkomponenten won.
  • the amplitude values represent measurements of the absorption spectrum at the five absorption lines used and the absorption minimum of the glucose.
  • the ratio of the amplitude values at the absorption lines to the amplitude value at the absorption minimum is a measure of the observed glucose concentration in the interstitial fluid in the stratum spinosum of the irradiated skin of the patient.
  • FIGS 2 and 3 illustrate views of the photoacoustic cell in cross section along vertical and horizontal planes.
  • the photoacoustic cell 2 has a body 20 of aluminum or stainless steel in which a cavity 21 is located.
  • the cavity 21 is shaped as a Helmholtz resonator with a bulbous main chamber 22 and a channel 23 branching therefrom.
  • a microphone 24 is arranged as an acoustic transducer for detecting an acoustic wave formed in the cavity 21 and for delivering the electrical measurement signal 7.
  • the main space 22 has on the underside of the body 20 an inlet opening 25 for the entry of the focused optical radiation 5 and on the upper side of the body 20. side of the body 20 an outlet opening for the exit of the optical radiation 5.
  • the patient places his or her palm on the exit port 26 so that it is completely covered by the skin 100 of the patient.
  • the inlet opening 25 may be closed with a zinc selenide window 27, which is permeable to medium infrared radiation. For the reasons mentioned above, however, it is advantageous to omit the window 27.
  • the cavity 21 is connected through the openings 25, 26 with the environment, and therefore air-filled.
  • the body 20 of the photoacoustic cell 2 contains a further cavity 28 with the same shape and dimensions as the cavity 21.
  • the further cavity 28 is provided with a further microphone 29.
  • the control circuit 3 subtracts the output of the other microphone 29 from the measurement signal 7 to reduce any noise due to ambient noise contained therein.
  • FIG. 4 shows the acoustic resonance spectrum of the Helmholtz resonator formed from the cavity 21 of the photoacoustic cell 2. Plotted is the achievable intensity over the frequency of the acoustic wave in the cavity 21.
  • the acoustic resonance spectrum has three main maxima at the frequencies 56, 60 and 64 kHz. Major maxima are those maxima where the photoacoustic intensity is at least twice the intensity at any other maximum. At these frequencies, the photoacoustic cell particularly intensifies the acoustic wave forming in the cavity. Therefore, these three resonance frequencies were selected as the repetition frequencies of the pulses of the quantum cascade lasers.
  • the number and position of the main maxima can be freely influenced by changing the dimensions of the Helmholtz resonator.
  • the optical source 1 includes six quantum cascade lasers for simultaneously measuring the glucose-specific absorption at six optical wavelengths of the absorption spectrum of glucose.
  • the quantum cascade lasers are operated with pulses of two different phase positions and three different repetition frequencies in order to be able to separate the respective components caused by them in the photoacoustic measuring signal.
  • the exact number is not essential. It is advantageous only if the photoacoustic cell has several main maxima in the ultrasonic range of its acoustic resonance spectrum and the pulse frequencies of the various quantum cascade lasers coincide with the different acoustic resonance frequencies at the main maxima.
  • a quantum cascade laser which is tuned successively to the optical wavelengths.
  • the quantum cascade lasers instead of the quantum cascade lasers, other narrow-band radiation sources in the mid-infrared range can also be used.
  • the quantum cascade lasers or other radiation sources within each pulse are operated in CW operation without any pulse falling into sub-pulses with radiationless gaps in between.
  • the entire pulse duration can be used to deliver optical energy and the amount of harmonics in the photoacoustic response, which would be disregarded due to the deviations from the pulse frequencies, can be reduced.
  • the pulse duration is about 0.1 to 1 ps to most efficiently use the energy of the radiation source.
  • FIG. 5 shows a photoacoustic cell which is a concrete embodiment of the cell of Figure 2.
  • the photoacoustic cell is shown enlarged in FIG. 5 and provided with dimensions in mm. It is shown in cross-section along the same plane as in Figure 2 and the same elements as in Figure 2 are provided with the same reference numerals.
  • the photoacoustic cell shown in FIG. 5 has no window 27.
  • the openings 25, 26 are thus windowless and unlocked, so that the cavity 21 is ventilated through these openings and result in the aforementioned advantages for the resonance behavior of the cell.
  • the main space 22 has a cylindrical shape and the two openings 25, 26 are located in the two opposite end faces of the cylindrical shape.
  • the inlet opening 25 has the same diameter as the main chamber 22.
  • the diameter of the outlet opening 26 is approximately one third of the diameter of the cylindrical main chamber 22.
  • the diameter of the outlet opening 26 is one-tenth to one-half the diameter of the cylindrical main chamber 22. In this area, on the one hand, a ensures sufficient planar irradiation of the patient on the outside of the outlet opening 26 laid finger or the palm and on the other hand prevents the skin of the patient can bulge so far into the cavity 21 that its geometry and acoustic properties are changed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Acoustics & Sound (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

De nombreuses applications de mesure photo-acoustique de substances dans un milieu, par exemple la mesure non invasive du taux de glucose sanguin dans l'organisme humain, exigent une sensibilité et une précision accrues. Ainsi, la présente invention concerne un dispositif photo-acoustique comprenant une source optique (1) et une cellule photo-acoustique (2). La cellule présente une fréquence de résonance acoustique dans le domaine des ultrasons et, pour délivrer un rayonnement optique, la source optique est commandée par des impulsions ayant une fréquence de répétition égale à la fréquence de résonance de la cellule photo-acoustique. De préférence, la cellule présente plusieurs fréquences de résonance et le rayonnement optique est constitué de composantes de rayonnement ayant différentes longueurs d'onde optiques et injectées à différentes fréquences de répétition des impulsions correspondant chacune à l'une des fréquences de résonance de la cellule photo-acoustique. Ceci permet en même temps de mesurer l'absorption du rayonnement optique à différentes longueurs d'onde. La cellule photo-acoustique comporte une cavité dotée de deux orifices sans fenêtre pour l'entrée et la sortie du rayonnement optique. Lorsque le dispositif est utilisé pour mesurer le taux de glucose sanguin dans l'organisme d'un patient, ce dernier pose la surface de la main ou du doigt sur l'orifice de sortie.
PCT/EP2013/000635 2012-03-05 2013-03-05 Dispositif photo-acoustique WO2013131637A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012004658.8A DE102012004658B4 (de) 2012-03-05 2012-03-05 Photoakustische Vorrichtung
DE102012004658.8 2012-03-05

Publications (1)

Publication Number Publication Date
WO2013131637A1 true WO2013131637A1 (fr) 2013-09-12

Family

ID=47884234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/000635 WO2013131637A1 (fr) 2012-03-05 2013-03-05 Dispositif photo-acoustique

Country Status (2)

Country Link
DE (2) DE102012004658B4 (fr)
WO (1) WO2013131637A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113876321A (zh) * 2021-11-09 2022-01-04 之江实验室 一种基于光声效应的无创血糖检测方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015009864B4 (de) 2014-08-09 2022-08-04 SAMTD GmbH & Co. KG Verfahren und Vorrichtung zur nicht-invasiven Bestimmung einer Messgröße eines Analyten in einem biologischen Körper

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348002A (en) * 1992-04-23 1994-09-20 Sirraya, Inc. Method and apparatus for material analysis
EP1048265A1 (fr) 1999-04-30 2000-11-02 V.Lilienfeld-Toal, Hermann, Prof. Dr. med. Dispositif et procédé de détection d'une substance
US20070197886A1 (en) * 2004-05-06 2007-08-23 Nippon Telegraph And Telephone Corporation Constituent Concentration Measuring Apparatus And Constituent Concentration Measuring Apparatus Controlling Method
US7304732B1 (en) * 2003-11-19 2007-12-04 United States Of America As Represented By The Secretary Of The Army Microelectromechanical resonant photoacoustic cell
US20100147051A1 (en) * 2008-12-11 2010-06-17 Honeywell International Inc. Apparatus and method for using the speed of sound in photoacoustic gas sensor measurements
US20110072886A1 (en) * 2009-09-30 2011-03-31 Catherine Genevieve Caneau Gas Sensor Based On Photoacoustic Detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963102B1 (fr) 2010-07-21 2017-01-13 Univ Reims Champagne Ardenne Procede et dispositif de detection de traces de gaz multiples

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348002A (en) * 1992-04-23 1994-09-20 Sirraya, Inc. Method and apparatus for material analysis
EP1048265A1 (fr) 1999-04-30 2000-11-02 V.Lilienfeld-Toal, Hermann, Prof. Dr. med. Dispositif et procédé de détection d'une substance
US7304732B1 (en) * 2003-11-19 2007-12-04 United States Of America As Represented By The Secretary Of The Army Microelectromechanical resonant photoacoustic cell
US20070197886A1 (en) * 2004-05-06 2007-08-23 Nippon Telegraph And Telephone Corporation Constituent Concentration Measuring Apparatus And Constituent Concentration Measuring Apparatus Controlling Method
US20100147051A1 (en) * 2008-12-11 2010-06-17 Honeywell International Inc. Apparatus and method for using the speed of sound in photoacoustic gas sensor measurements
US20110072886A1 (en) * 2009-09-30 2011-03-31 Catherine Genevieve Caneau Gas Sensor Based On Photoacoustic Detection

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113876321A (zh) * 2021-11-09 2022-01-04 之江实验室 一种基于光声效应的无创血糖检测方法
CN113876321B (zh) * 2021-11-09 2023-09-08 之江实验室 一种基于光声效应的无创血糖检测方法

Also Published As

Publication number Publication date
DE102012004658A1 (de) 2013-09-05
DE202013012102U1 (de) 2015-03-25
DE102012004658B4 (de) 2023-06-15

Similar Documents

Publication Publication Date Title
EP3359949B1 (fr) Dispositif et procédé pour analyser une substance
EP1493019B1 (fr) Dispositif de mesure a infrarouge, conu en particulier pour la spectrometrie de systemes aqueux et non aqueux
EP3359948B1 (fr) Dispositif et procédé pour analyser une substance
DE10311452B4 (de) Analysesystem zur reagenzienfreien Bestimmung der Konzentration eines Analyten im lebenden Gewebe
DE10027100C2 (de) Verfahren und Vorrichtung zum Nachweisen von Substanzen in Körperflüssigkeiten
DE102014108424B3 (de) Nicht-invasive Stoffanalyse
DE102006036920B3 (de) Verfahren zur Messung der Glukosekonzentration in pulsierendem Blut
DE69837425T2 (de) Verfahren und Vorrichtung zur nichtinvasiven photoakustischen Messung von Blutglukose
DE69737363T2 (de) Überwachung von gewebe-bestandteilen mittels infrarot-strahlung
DE60310286T2 (de) Vorrichtung und Verfahren zur nicht-invasiven Bestimmung der Konzentrationen von biologischen Flüssigkeiten mittels photoakustischer Spektroskopie
EP0774658B1 (fr) Procédé et dispositif de détermination de données analytiques concernant l'intérieur d'un milieu diffusant
EP0726729B1 (fr) Procede et dispositif permettant de determiner la concentration de glucose dans une matrice biologique
EP0876596B1 (fr) Procede et dispositif de determination d'un analyte contenu dans une matrice de diffusion
DE69104203T2 (de) Verfahren und gerät zur messung des blut-glukose-gehaltes in vivo.
DE4400674C2 (de) Photoakustischer Sensor
EP2235485B1 (fr) Procédé de détermination optique non effractive de la température de sang circulant à l'intérieur d'un corps vivant
WO1994010901A1 (fr) Procede et dispositif d'analyse de glucose dans une matrice biologique
WO2007000297A1 (fr) Detecteur photoacoustique en champ libre
EP2997883A1 (fr) Procédé et agencement de mesure d'absorption optique
DE102012004658B4 (de) Photoakustische Vorrichtung
EP0771546B1 (fr) Procédé pour la détection du flux sanguin et/ou d'un liquide intra- et/ou extracorporel coulant dans un tissue biologique
DE102015009863A1 (de) Verfahren und Vorrichtung zur nicht-invasiven Bestimmung einer Messgröße eines Analyten in einem biologischen Körper
DE102015009864B4 (de) Verfahren und Vorrichtung zur nicht-invasiven Bestimmung einer Messgröße eines Analyten in einem biologischen Körper
DE102015007871B4 (de) Verfahren und Vorrichtung zur nicht-invasiven Bestimmung einer Messgröße eines Analyten in einem biologischen Körper
DE10143783A1 (de) Vorrichtung und Verfahren zur Messung der Konzentration mindestens einer Substanz in einer Probe

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13709322

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13709322

Country of ref document: EP

Kind code of ref document: A1